Clinical analysis of trimetazidine, levocarnitine and Huangqi injection in the treatment of acute viral myocarditis

Objective To discuss the clinical effect of the trimetazidine,levocarnitine and Huangqi injection in the treatment of acute viral myocarditis. Methods 112 patients with AVM were randomly divided into two groups(observation group and control group),56 cases in each group, the control group was treated by the Huangqi injection combined with levocarnitine, and the observation group was treated by the trimetazidine on the basis of the control group, and the electrocardiographic,the improvement of clinical symptoms, the improvement of serum markers situation, cardiac function of two groups were observed. Results The total effective rate of the observation group was 98.21%, the control group was 82.14%,the difference was statistically significant(P0.05). After the treatment, the clinical improvement rate of the observation group was significantly higher than the control group, and the difference was statistically significant (P0.05). The cardiac function improvement rate of the observation group was better than the control group, and the difference was statistically significant(P0.05).Conclusion The trimetazidine,levocarnitine and Huangqi injection in the treatment of the acute viral myocarditis, can improve the total effective rate, improve symptoms, ECG and myocardial enzymes, restore heart function, prevent myocardial injury and adverse reactions are mild, so it canbe used as AVM treatment methods.